Description générale
Neostigmine is a reversible anticholinesterase agent indicated as a treatment for myasthenia gravis; and for use in the reversal of non-depolarizing muscle relaxants administered during surgery.
INN
Neostigmine bromide
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 1977
(TRS
615)
pour
Anticholinesterase reversible
Ajouté en 1977
(TRS
615)
pour
Myasthenia gravis
Wikipédia
DrugBank
Recommandations
Section
Muscle relaxants (peripherally-acting) and cholinesterase inhibitors
- Oral > Solid: 15 mg (neostigmine bromide)
- Parenteral > General injections > unspecified: 0.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate); 2.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate)
Indications